The Trump administration withdraws the nomination for the new director of FDA; institutional leadership again falls into turmoil
2026-11-18 08:30:31
According to CoinMeta, the Trump administration has withdrawn its nomination of White House aide Heidi Overton for the position of Director of the U.S. Food and Drug Administration (FDA). As the political obstacles to filling this position become increasingly complex, FDA will continue to be without a formal director. A senior government official stated that due to a lack of congressional support, the White House decided to withdraw the nomination. The Senate Health, Education, Labor, and Pensions Committee was scheduled to vote on Wednesday to decide whether to recommend submitting Overton's nomination to the full Senate for a vote. This withdrawal of the nomination will extend the period of instability for FDA. The former director, Marty Makary, resigned in May of this year; he held this top position for only 13 months and encountered conflicts with agency staff during his tenure, as well as opposition from biotechnology companies. It is currently unclear whether the White House will be able to push forward with a new nomination before Democrats take control of the Senate in January next year.
Bullish 0
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.